Jiangsu New-bio Biotechnology

Jiangsu New-bio Biotechnology is a specialized in vitro diagnostics (IVD) company based in Taizhou, China. The company focuses on the research, development, and commercialization of automated chemiluminescence immunoassay (CLIA) systems and a comprehensive menu of diagnostic reagents. Their core technology utilizes magnetic microbead-based chemiluminescence to provide high-sensitivity detection for various clinical markers. New-bio's product portfolio includes diagnostic panels for cardiac health, inflammation, oncology, and infectious diseases. The company serves clinical laboratories and healthcare institutions globally, providing integrated solutions for automated immunoassay testing.